期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

英夫利西单抗治疗斑块状银屑病的疗效观察与护理 被引量：4

Curative effect observation of infliximab in treatment of plaque psoriasis and its nursing care
下载PDF
导出
摘要 银屑病是一种慢性复发性炎症性皮肤病。Ortonne等推测欧洲银屑病患病率约为2%,Wozel等报道德国银屑病患病率为1.5%-2%。根据我国6个城市调查结果推测,我国银屑病患病率为0.47%,即现有银屑病患者约624万。银屑病给患者带来了极大的困扰,严重影响患者的生活质量。传统的一线治疗药物包括阿维A、甲氨喋呤、环孢素等,在治疗过程中,上述药物存在着不同程度的肝肾毒性、
作者 裴璐 王妍妍 曹春艳
机构地区 中国医学科学院皮肤病医院
出处 《实用皮肤病学杂志》 2016年第3期208-209,共2页 Journal of Practical Dermatology
关键词 银屑病 英夫利西 护理
分类号 R473.75 [医药卫生—护理学]
  • 相关文献

参考文献5

二级参考文献56

  • 1i~iheller P, I.akatos PL, Horvcith G, et al. Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe a Hungarian nationwide observational study. BMC Gastroenterol, 2009 ; 9 : 66.
  • 2Peyrin Biroulet L, Dehenre P, de Suray N, et al. Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta analysis of placebo-controlled trials. Clin Gastroenterol Hepatol,2008;6(6) :644-653.
  • 3Daperno M, D' Haens G, Van Assche G, et al. Development and validationof a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc, 2004;60 (4) :505-512.
  • 4Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care, 1996 ; 34 (3) :220-233.
  • 5Jenkinson C, Layte R, Jenkinson D, et al. A shorter form health survey:can the SF-12 replicate results from the SF-36 in longitudinal st udies? J Public Health Med, 1997 ; 19 ( 2 ) : 179-186.
  • 6Hanauer SB, Feagan BG, Lichtenstein GR, et al. ACCENT I Study Group. Maintenance infliximab for Crohn~s disease: the ACCENT I randomised trial. Lancet, 2002 ; 359 (9317) :1541-1549.
  • 7Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn' s disease. N Engl J Med,2004;350(9) :876-885.
  • 8Tanaka S, Matsuo Ks Sasaki T, et al. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed? Hepatogastroenterology, 2010 ; 57 (97) 3-7.
  • 9D'Ovidio V, Aratari A, Viseido A, et al. Infliximab and quality of life in steroid-dependent Crohn~s disease. Dig Liver Dis, 2004;36(8) :557-558.
  • 10Wee CC, Davis RB, Hamel MB. Comparing the SF-12 and SF- 36 health status questionnaires in patients with and without obesity. Health Qual Life Outcomes, 2008 ; 6 : 11.

共引文献9

同被引文献22

引证文献4

二级引证文献13

实用皮肤病学杂志
2016年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部